13F filer · CIK 1009207 ↗
D. E. Shaw
You are looking at Q1 2018. See the latest, Q2 2026 →
Reported value
$73.46B
+1.2% on the quarter before
Positions
3,444
480 new · 582 sold out
Top 10
9.5%
of the value
Est. gain
−$207.4M
on stocks held all quarter
Est. return
−0.5%
on those stocks since Q4 2017
Positions as of Mar 31, 2018, from D. E. Shaw's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 17% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2017. Striped tiles are options.
Largest buys
Since Q4 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Lowes Cos Inc~$591.3MAdded · 0.2% → 1.0%+6,738,988 shares
- Nvidia~$454.0MAdded · 0.1% → 0.8%+1,960,529 shares
- Booking Hldgs Inc~$405.2MNew · 0.0% → 0.6%+194,767 shares
- Eqt Corp~$360.6MAdded · 0.2% → 0.6%+7,590,309 shares
- Citigroup Inc~$331.7MAdded · 0.2% → 0.7%+4,914,661 shares
- Celgene Corp~$314.9MAdded · 0.1% → 0.5%+3,529,714 shares
- Aetna Inc New~$274.9MAdded · 0.1% → 0.5%+1,626,332 shares
- Twitter Inc~$217.2MAdded · 0.1% → 0.4%+7,488,733 shares
- Booking Hldgs IncPUT~$210.5MNew · 0.0% → 0.3%+101,200 underlying
- Vmware Inc~$200.4MAdded · 0.2% → 0.5%+1,652,210 shares
Largest sells
Since Q4 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Meta~$617.7MCut · 1.1% → 0.1%−3,865,650 shares
- Dell Technologies Inc~$463.1MCut · 0.7% → 0.0%−6,326,032 shares
- Priceline Grp IncPUT~$396.7MSold out · 0.5% → 0.0%−228,300 underlying
- IBM~$331.0MCut · 0.7% → 0.3%−2,157,110 shares
- Amgen Inc~$283.8MCut · 0.6% → 0.2%−1,664,954 shares
- Johnson & Johnson~$250.4MCut · 0.6% → 0.2%−1,954,286 shares
- Monsanto Co New~$248.9MCut · 0.4% → 0.1%−2,133,347 shares
- Priceline Grp Inc~$228.2MSold out · 0.3% → 0.0%−131,326 shares
- Comcast Corp New~$226.4MCut · 0.7% → 0.3%−6,626,929 shares
- Time Warner Inc~$192.5MCut · 1.1% → 0.9%−2,035,164 shares
Holdings
As of Mar 31, 2018. Changes are in shares against Dec 31, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nxp Semiconductors N VCOM · shares +24% · price −0.1% | 1.4% | $1.03B | −$636,630 | ||||||||
| AppleCOM · shares +3.5% · price −0.9% | 1.3% | $941.6M | −$7.9M | ||||||||
| Merck & Co IncCOM · shares +19% · price −3.2% | 1.2% | $895.1M | −$24.8M | ||||||||
| Lowes Cos IncCOM · shares +354% · price −5.6% | 1.0% | $758.4M | −$9.9M | ||||||||
| Time Warner IncCOM NEW · shares −23% · price +3.4% | 0.88% | $648.4M | +$21.3M | ||||||||
| AlphabetCAP STK CL A · shares −2.6% · price −1.5% | 0.87% | $642.5M | −$10.1M | ||||||||
| NvidiaCOM · shares +355% · price +19.7% | 0.79% | $581.8M | +$21.0M | ||||||||
| Visa Inc.COM CL A · shares +13% · price +4.9% | 0.70% | $517.7M | +$21.5M | ||||||||
| Verisign IncCOM · shares −4.7% · price +3.6% | 0.68% | $497.7M | +$17.3M | ||||||||
| Citigroup IncCOM NEW · shares +203% · price −9.3% | 0.67% | $495.4M | −$16.7M | ||||||||
| Bristol Myers Squibb CoCOM · shares +68% · price +3.2% | 0.66% | $485.3M | +$9.0M | ||||||||
| S&P Global IncCOM · shares −13% · price +12.8% | 0.64% | $470.4M | +$53.3M | ||||||||
| Eqt CorpCOM · shares +340% · price −16.5% | 0.64% | $466.8M | −$21.0M | ||||||||
| Broadcom LtdSHS · shares +51% · price −8.3% | 0.58% | $426.4M | −$25.5M | ||||||||
| General Electric CoCOM · shares +8.4% · price −22.8% | 0.58% | $425.4M | −$115.6M | ||||||||
| T Mobile Us IncCOM · shares +10% · price −3.9% | 0.56% | $411.6M | −$15.1M | ||||||||
| Booking Hldgs IncCOM · shares New | 0.55% | $405.2M | — | ||||||||
| Applied MaterialsCOM · shares +63% · price +8.8% | 0.55% | $401.8M | +$19.9M | ||||||||
| AmazonPUTCOM · shares −1.3% | 0.53% | $387.3M | — | ||||||||
| AlphabetCAP STK CL C · shares −28% · price −1.4% | 0.52% | $385.2M | −$5.5M | ||||||||
| MicrosoftCOM · shares +50% · price +6.7% | 0.52% | $383.3M | +$16.0M | ||||||||
| Celgene CorpCOM · shares +467% · price −14.5% | 0.52% | $382.4M | −$11.5M | ||||||||
| Tjx Cos Inc NewCOM · shares −15% · price +6.7% | 0.52% | $381.4M | +$23.8M | ||||||||
| Marathon Pete CorpCOM · shares −7.4% · price +10.8% | 0.52% | $380.7M | +$37.1M | ||||||||
| Pg&E CorpCOM · shares +63% · price −2.0% | 0.51% | $375.2M | −$4.7M | ||||||||
| Total · 3,444 positions | 100% | $73.46B | −$207.4M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2017 to Q1 2018: 2,164 stocks held throughout, down $207.4M (−0.5%).
- Netflix+$104.6M+54%
- Herbalife Ltd+$61.9M+44%
- S&P Global Inc+$53.3M+13%
- Amazon+$41.9M+24%
- Marathon Pete Corp+$37.1M+11%
- Comcast Corp New−$31.9M−15%
- Qualcomm−$32.3M−13%
- Exact Sciences Corp−$33.7M−23%
- Cigna Corporation−$42.1M−17%
- General Electric Co−$115.6M−23%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $210.20B+26% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $166.31B−9% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $182.42B+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $177.16B+26% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $141.06B+26% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $112.35B−18% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $136.27B+17% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $116.49B+9% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $106.92B−8% | SEC ↗ |
| Q1 2024 | May 15, 2024 (amended) | $116.85B+2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 (amended) | $114.44B+19% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $95.78B−2% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $97.90B+5% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $93.41B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $90.48B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $83.73B−2% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $85.30B−20% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $106.83B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $120.60B+9% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $110.81B−4% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $115.86B+12% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $103.59B−7% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $111.85B+14% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $97.71B+16% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $83.95B+31% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $64.09B−27% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $87.45B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $81.21B+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $80.19B+4% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $77.39B+7% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $72.58B−13% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $83.24B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $76.66B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $73.46B+1% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $72.62B+12% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $65.09B+8% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $60.46B+6% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $56.89B−3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $58.87B+4% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $56.68B+5% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $54.23B−3% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $55.73B | SEC ↗ |